Skip to main content
OpenTrials
Completed

NCT Number: NCT00810433

A Clinical Study of the GO-LIF® Approach for Lumbar Spinal Fixation

The purpose of this study is to collect data regarding the safety and feasibility of the GO-LIF procedure for spinal fixation and stabilization, in conjunction with conventional approaches for interbody lumbar fusion. This is in order to allow for evidence-based comparison to pedicle-screw-based techniques as described in the literature.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dep. Of Neurosurgery , Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin (CBF), Berlin, Germany

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women, 18-80 years of age.
  • The capability to comprehend the nature and rationale of the study and to consent to participating in the study.
  • Unequivocal medical indication for the fixation surgery of a single motion segment of the lumbar spine.
  • Correct coronal profile of the lumbar spine. An asymmetric collapse of the disk space in the coronal plane between the vertebral bodies envisioned for instrumentation is by itself not an exclusion criterion.

Or any of criteria below:

  • Patients with Grade II or Grade III spondylolisthesis in the sagittal plane with preserved or normal sagittal alignment requiring single-level instrumented interbody fusion from L1 to S1. (Not excluding patient with a need to decompression)
  • Patients must have normal alignment of the spine in the coronal view. 2. The interbody fusion approach may be TLIF or PLIF or ALIF or other, as clinically indicated.
  • The procedure may be combined with a Micro-decompression and/or Micro-discectomy and/or direct or indirect decompression and/or laminectomy or laminotomy and/or other procedures, as clinically indicated - as long as such procedures do not compromise the structural integrity of the pedicles of the inferior vertebra or the vertebral body of either vertebra of the levels involved..
  • Patient is 18 years or more 5. Patient is willing and able to comply with study requirements

Exclusion criteria

  • Lumbar hyperlordosis > 70° between the end plate of the lumbar vertebral body 1 and the end plate of the sacral vertebral body 1.
  • Deformities of the vertebral bodies envisioned for instrumentation or the sacrum.
  • Spondylolisthesis > grade 2 acc. to Meyerding.
  • Scoliosis and other deformities in the coronal plane.
  • Fractures of the vertebrae envisioned for instrumentation.
  • Osteoporosis or osteopenia (see below for examination criteria).
  • Therapy with systemic corticosteroids or immunosuppressants.
  • Bone metabolism diseases, such as osteomalacia or Paget's disease.
  • Post inflammatory instability of the vertebral spine.
  • State after radiation therapy of the relevant vertebral spine region.
  • Current Marcoumar or heparin therapy for more than 6 months at the time of operation.
  • Malignant diseases with or without bone metastases.
  • Immunologic-inflammatory diseases (e.g., rheumatoid arthritis).
  • Diabetes mellitus.
  • Infectious diseases.
  • BMI > 30.

Treatment and study plan

GO-LIF - Guided Oblique Lumbar Interbody Fusion

Procedure

All patients will undergo single-level instrumented interbody spinal fusion surgery with instrumentation.

Upon induction of general anesthesia, the patient will be positioned prone on a radiolucent operating table and prepared according to standard hospital procedure. An interbody fusion will be performed according to standard procedure and as indicated by the surgeon. The interbody fusion portion of the surgery will be carried out using any current technique - such as PLIF, TLIF, PLF, PLLF, XLIF or ALIF. The fusion strategy can be performed in an open or minimally invasive manner, as indicated. The interbody device will be inserted after the screws trajectory will be drilled and a 4.5mm Trajectory holder is in place. This will assure the surgeon that no collision will occur between the interbody and the screws.

Upon completion of the fusion stage of the surgery, SpineAssist will be used to introduce the GO-LIF screws for fixation of the spinal levels to be fused.

Other names: Mazor, SpineAssist, GO-LIF

Primary outcomes

  1. The number, severity and causality of intra-operative and post-operative complications, with particular attention to nerve root irritation or injury.

    Time frame: prior to discharge from hospital

  2. Number of significant cortical breaches (>4mm), as evidenced by visual examination of a post-operative CT scan.

    Time frame: Preferably prior to discharge from hospital, and no later than 1 month post-op

  3. The number of procedures that were not completed, and the reasons and causality for non-completions.

    Time frame: Immediately post-op.

Secondary outcomes

  1. Plain AP, Lateral and flexion-extension radiographs. The radiographs will be examined for: • Evidence of bridging trabecular bone between the involved motion segments • Translational motion <3mm; and •Angular motion <5 degrees.

    Time frame: 3, 6 and 12 months post-op.

  2. Healthcare Outcomes: the visual analogue pain scale (VAS), the Oswestry disability index (ODI) and Swiss Spinal Stenosis (SSS) Questionnaire.

    Time frame: pre-op; 3, 6 and 12 months post-op

Sponsors and collaborators

Lead sponsor

Mazor Robotics

Industry

Registry information

Official study title

A Clinical Safety and Feasibility Study of the GO-LIF® Approach

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Dec 18, 2008
Registry last updated
Feb 7, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.